Literature DB >> 7474086

Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses.

U R de Verdugo1, H C Selinka, M Huber, B Kramer, J Kellermann, P H Hofschneider, R Kandolf.   

Abstract

Viral infection of host cells primarily depends on binding of the virus to a specific cell surface protein. In order to characterize the binding protein for group B coxsackieviruses (CVB), detergent-solubilized membrane proteins of different cell lines were tested in virus overlay protein-binding assays. A prominent virus-binding protein with a molecular mass of 100 kDa was detected in various CVB-permissive human and monkey cell lines but was not detected in nonpermissive cell lines. The specificity of CVB binding to the 100-kDa protein on permissive human cells was substantiated by binding of all six serotypes of CVB and by competition experiments. In contrast, poliovirus and Sendai virus did not bind to the 100-kDa CVB-specific protein. A fraction of HeLa membrane proteins enriched in the range of 100 kDa showed functional activity by transforming infectious CVB (160S) into A-particles (135S). In order to purify this CVB-binding protein, solubilized membrane proteins from HeLa cells were separated by preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by elution of the 100-kDa protein. Amino acid sequence analysis of tryptic fragments of the CVB-binding protein indicated that this 100-kDa CVB-specific protein is a cell surface protein related to nucleolin. These results were confirmed by immunoprecipitations of the CVB-binding protein with nucleolin-specific antibodies, suggesting that a nucleolin-related membrane protein acts as a specific binding protein for the six serotypes of CVB.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474086      PMCID: PMC189586     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Unrelated animal viruses share receptors.

Authors:  K Lonberg-Holm; R L Crowell; L Philipson
Journal:  Nature       Date:  1976-02-26       Impact factor: 49.962

2.  Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily.

Authors:  C L Mendelsohn; E Wimmer; V R Racaniello
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

3.  Detection of the human rhinovirus minor group receptor on renaturing Western blots.

Authors:  H Mischak; C Neubauer; B Berger; E Kuechler; D Blaas
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

Review 4.  The current state of two-dimensional electrophoresis with immobilized pH gradients.

Authors:  A Görg; W Postel; S Günther
Journal:  Electrophoresis       Date:  1988-09       Impact factor: 3.535

5.  Copper staining: a five-minute protein stain for sodium dodecyl sulfate-polyacrylamide gels.

Authors:  C Lee; A Levin; D Branton
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

6.  Major nucleolar proteins shuttle between nucleus and cytoplasm.

Authors:  R A Borer; C F Lehner; H M Eppenberger; E A Nigg
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

7.  Cell adhesion-dependent differences in endogenous protein phosphorylation on the surface of various cell lines.

Authors:  J Pfeifle; W Hagmann; F A Anderer
Journal:  Biochim Biophys Acta       Date:  1981-09-29

8.  Cloning and sequencing of the human nucleolin cDNA.

Authors:  M Srivastava; P J Fleming; H B Pollard; A L Burns
Journal:  FEBS Lett       Date:  1989-06-19       Impact factor: 4.124

9.  The major human rhinovirus receptor is ICAM-1.

Authors:  J M Greve; G Davis; A M Meyer; C P Forte; S C Yost; C W Marlor; M E Kamarck; A McClelland
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

10.  Specific alterations of coxsackievirus B3 eluted from HeLa cells.

Authors:  R L Crowell; L Philipson
Journal:  J Virol       Date:  1971-10       Impact factor: 5.103

View more
  33 in total

1.  Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.

Authors:  Steven D Carson; Nora M Chapman; Susan Hafenstein; Steven Tracy
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 2.  Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism.

Authors:  Hans-Christoph Selinka; Antje Wolde; Martina Sauter; Reinhard Kandolf; Karin Klingel
Journal:  Med Microbiol Immunol       Date:  2003-08-14       Impact factor: 3.402

3.  Nuclear targeting by the growth factor midkine.

Authors:  Yoshihisa Shibata; Takashi Muramatsu; Makoto Hirai; Tatsuya Inui; Terutoshi Kimura; Hidehiko Saito; Lynn M McCormick; Guojun Bu; Kenji Kadomatsu
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

4.  Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers.

Authors:  D R Anderson; C M Carthy; J E Wilson; D Yang; D V Devine; B M McManus
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization.

Authors:  Cory M Robinson; James F Sinclair; Michael J Smith; Alison D O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

Review 6.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

7.  Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor.

Authors:  S Neff; D Sá-Carvalho; E Rieder; P W Mason; S D Blystone; E J Brown; B Baxt
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 8.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

9.  Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells.

Authors:  Santanu Bose; Mausumi Basu; Amiya K Banerjee
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Stat1 nuclear translocation by nucleolin upon monocyte differentiation.

Authors:  Uwe Jerke; Sergey Tkachuk; Julia Kiyan; Victoria Stepanova; Angelika Kusch; Michael Hinz; Rainer Dietz; Hermann Haller; Bianca Fuhrman; Inna Dumler
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.